KR

Kumaraguru Raja

Brookline Capital
Automatically Tracked
Tracking: 0 Updated: 20 hours ago

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
-76.48%
Gain -5.41%
Monthly
-2.57%
Yearly
-26.86%
Drawdown
99.91%
$355,068.57
Equity
Holdings
-$52,870.07
Cash
$407,938.63
Investment
$684,677.18
-$1.21M
Profit -$20,297.06
Realized
-$470,911.81
Unrealized
-$737,547.25
Dividends
$0
$407,938.63
Cash
Deposits
$1.56M
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-5.41%
Profit
-$20,297.06
Win %
50%
This Week
Compared To Last Week
Gain
-5.88%
Profit
-$22,164.88
Win %
50%
This Month
Compared to last month
Gain
506.79%
Profit
$296,552.54
Win %
50%
This Year
Compared to last year
Gain
-189.01%
Profit
$753,958.13
Win %
50%
Forte Biosciences, Inc. logo
FBRX Forte Biosciences, Inc.
+1.48%
-$20,631.45
Adial Pharmaceuticals Inc. logo
ADIL Adial Pharmaceuticals Inc.
-5.46%
+$334.39
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
58
Longs Won
15/48 31%
Profit Factor
0.13
Profitability
Shorts Won
1/10 10%
Standard Deviation
$121,230.13
Average Win
$11,312.24
Best Trade
(Jun 22) $75,014.46
Sharpe Ratio
-49.7
Average Loss
-$33,082.26
Worst Trade
(Jun 22) -$812,561.71
Z-Score
-3.55 (100%)
Commissions
$0
Avg. Trade Length
3m 4w 1d
Expectancy
-$20,835.5
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss - - - - - - - - - -
Consecutive Losing Trades 11 10 9 8 6 5 4 3 2 1
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV